Clinical Trial Update: Transvaginal Human Acellular Dermal Matrix for Prolapse Treatment [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update on using transvaginal human acellular dermal matrix for pelvic organ prolapse, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pelvic Organ Prolapse
• Uterine Prolapse
• Vaginal Prolapse

Drugs mentioned

• Transvaginal Human Acellular Dermal Matrix (acellular dermal matrix)

Snippet

Sponsor: Hospital Mutua de Terrassa | Conditions: Prolapse; Female, Prolapse Genital | Phase 2 | Status: RECRUITING